Www.metcardio.org CURRENT PUBLICATION TRENDS IN INTERVENTIONAL CARDIOLOGY Giuseppe Biondi Zoccai Division of Cardiology, University of Turin, Turin, Italy.

Slides:



Advertisements
Similar presentations
Clinical Writing for Interventional Cardiologists.
Advertisements

Ghanem et al., J Am Coll Cardiol 2010;55:1427–32..
When PCI in NSTEMI? Giuseppe Biondi Zoccai, MD Department of Medico-Surgical Sciences and Biotechnologies Sapienza University of Rome.
After cardiac arrest: emergency coronary angiography for all? Giuseppe Biondi-Zoccai, MD Sapienza University of Rome, Italy
STENT THROMBOSIS: WHICH IMPACT IN REAL CLINICAL PRACTICE? Giuseppe Biondi Zoccai Divisione di Cardiologia, Università di Torino Ospedale S. Giovanni Battista.
Prasugrel vs ticagrelor in acute coronary syndromes
Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy Educational Fellowship in PCI.
Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.
Novel antithrombotic agents in acute coronary syndromes: better or worse than P2Y12 inhibitors Giuseppe Biondi Zoccai Sapienza Università di Roma
Pros and cons of FFR in multivessel disease: from FAME to ACS Giuseppe Biondi Zoccai University of Modena and Reggio Emilia, Modena, Italy
Giuseppe Biondi-Zoccai Division of Cardiology, University of Turin, Turin, Italy.
New generation devices for the femoro-popliteal district Giuseppe Biondi Zoccai University of Modena and Reggio Emilia
Biondi-Zoccai: Peripheral interventions – metcardio.org Basic principles of peripheral interventions Giuseppe Biondi Zoccai University.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study by Peter Barlis, Evelyn.
A meta-analysis of percutaneous versus surgical closure of ostium secundum atrial septal defects Butera G, Biondi-Zoccai G, Abella R, Piazza L, Chessa.
ACUTE CORONARY SYNDROMES:
8 February 2012, 12:30-13:10 A journey into bioclinical evidence: from bench... to bedside... to population Giuseppe Biondi Zoccai
A Systematic Review On The Hazards Of Aspirin Discontinuation Among Patients With Or At Risk For Coronary Artery Disease Giuseppe Biondi Zoccai Hemodynamics.
RITA-3 Is this a benign lesion in a benign condition? Who Needs Angioplasty in 2008? Stable Angina Stable Angina Keith A A Fox Professor of Cardiology.
Elective Stenting versus Balloon Angioplasty with Bail-out Stenting for Small Vessel Coronary Artery Disease: Evidence from a Meta-analysis of Randomized.
Tips and tricks for performing standard meta-regression analysis with SPSS Giuseppe Biondi Zoccai Division of Cardiology, Department of Internal Medicine,
Applications of bivalirudin in interventional cardiology
Radial versus Femoral Approach for Percutaneous Coronary Procedures: A Meta-analysis of Randomized Trials 6th EUROPEAN WORKSHOP ON TRANSRADIAL APPROACH.
ATTEMPT study: pooled-Analysis of Trials on ThrombEctomy in acute Myocardial infarction based on individual PatienT data CLINICAL TRIAL UPDATE III ESC.
PCI vs. CABG: Review of the evidence and suggestions Giuseppe Biondi Zoccai Division of Cardiology, University of Turin, Turin, Italy.
Primer on Statistics for Interventional Cardiologists Giuseppe Sangiorgi, MD Pierfrancesco Agostoni, MD Giuseppe Biondi-Zoccai, MD.
Giuseppe Biondi Zoccai Division of Cardiology University of Turin, Turin Critical aspects of trials on the new generation DES 31st.
Is personalized medicine a hoax? Giuseppe Biondi Zoccai, MD University of Modena and Reggio Emilia
Biondi-Zoccai: CT & coronary angiography – metcardio.org Why coronary CT is inferior to invasive coronary angiography Giuseppe.
Giuseppe Biondi Zoccai Interventional Cardiology, University of Turin, Italy Results of drug-eluting stent randomized trials: separating.
Mechanical devices for cardiac massage: must-have or luxury? Mechanical devices for cardiac massage: must-have or luxury? Giuseppe Biondi-Zoccai, MD Sapienza.
COMPLETE REVASCULARIZATION IN ELDERLY - When it’s contraindicated
Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy JOINT SYMPOSIUM WITH JACCT - Bologna, 25/9/2008.
Why are drug-eluting stents safer than bare-metal stents? Giuseppe Biondi Zoccai, MD Sapienza University of Rome, Rome, Italy METCARDIO,
PRACTICAL RECOMMENDATIONS ON ANTI- THROMBOTIC TREATMENT IN PATIENTS TREATED WITH DRUG-ELUTING STENTS Giuseppe Biondi-Zoccai Ospedale S. Giovanni Battista.
Thrombectomy: beneficial (if ever) only in highly selected patients Prof. Imad Sheiban University of Turin, Turin, Italy.
Follow-up Clinico e Trattamento Post- Rivascolarizzazione Percutanea Giuseppe Biondi Zoccai University of Turin, Turin, Italy Marrakesh,
Drug-eluting stent meta-analyses & Long-term follow-up of high-risk subsets: Reconciling the evidence DES e BMS: riflessioni e pensieri 23 febbraio 2007,
Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy BMS & Sanofi Aventis Sponsored.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Drug-Eluting Stents in Challenging Lesions: Randomized Trials and Registries.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Prasugrel in all ACS Patients! Giuseppe Biondi-Zoccai, MD Sapienza University of Rome, Italy
Is the Debate Over? Routine Thrombus Aspiration in STEMI (From TAPAS to INFUSE-AMI to TASTE to TOTAL) Stefan James Professor of Cardiology Uppsala Clinical.
Novel Trial Design Focus - Left Main and “All Comers” DES Studies: All-Comers Studies. Interventional View Jeffrey J. Popma, MD Director, Innovations in.
Issues and Current Situations in the Development of Endovascular Treatment Devices for Pediatric Cardiology in the US – US Industry Dan Gutfinger, MD,
Giuseppe Biondi Zoccai, M.D.
What´s New in the Literature on Transradial Intervention
Primer on Adjusted Indirect Comparison Meta-Analyses
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Giuseppe Biondi Zoccai
Giuseppe Biondi Zoccai
Background There is ongoing debate to identify the most effective drug-eluting stent between the two currently most used devices (ie, sirolimus- [SES]
Giuseppe Biondi Zoccai University of Turin, Turin, Italy
Incidence And Management Of Restenosis After Treatment Of Unprotected Left Main Disease With Drug-Eluting Stents: 70 Restenotic Cases From A Cohort Of.
Giuseppe Biondi Zoccai, MD
AN INTERNATIONAL COLLABORATIVE META-ANALYSIS ON 1,274 PATIENTS UNDERGOING PERCUTANEOUS DRUG-ELUTING STENTING FOR UNPROTECTED LEFT MAIN CORONARY ARTERY.
SURGERY EARLY AFTER DES IMPLANTATION
Benefits of complete coronary revascularization – Counterpoint: what are you talking about? Giuseppe Biondi Zoccai, MD University of Modena and Reggio.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
PREDICTORS OF ADVERSE EVENTS IN PATIENTS WITH UNPROTECTED LEFT MAIN DISEASE TREATED WITH DRUG-ELUTING STENTS: EVIDENCE FROM A COLLABORATIVE META-REGRESSION.
CHRONIC TOTAL OCCLUSIONS: WHAT IS KNOWN AND
Single Versus Multiple Vessel Stenting In Patients With St-Elevation Myocardial Infarction: Results From A 30,886-Patient Meta-Analysis Giuseppe Biondi.
Comparison of radial versus femoral access in patients undergoing invasive management for acute coronary syndromes: evidence from a systematic review and.
Is Prasugrel Superior To Ticagrelor For The Treatment Of Patients With Acute Coronary Syndromes? Evidence From A 32,893-Patient Adjusted Indirect Comparison.
Nat. Rev. Cardiol. doi: /nrcardio
Clinical case report platform
Presentation transcript:

CURRENT PUBLICATION TRENDS IN INTERVENTIONAL CARDIOLOGY Giuseppe Biondi Zoccai Division of Cardiology, University of Turin, Turin, Italy Meta-analysis and Evidence-based medicine Training in Cardiology (METCARDIO), Ospedaletti, Italy

LEARNING GOALS What is publishing in interventional cardiology all about? What do we mean by current trends in publication? What is currently being published and by who? – methods – on coronary artery disease – on non-coronary heart disease – on vascular disease

WHY AM I GIVING YOU THIS LECTURE? ISI Web of Science query for AU=(Zoccai OR Biondi- Zoccai OR Biondizoccai) on 21 September 2009

LEARNING GOALS What is publishing in interventional cardiology all about? What do we mean by current trends in publication? What is currently being published and by who? – methods – on coronary artery disease – on non-coronary heart disease – on vascular disease

PUBLISH OR PERISH

“Scientists are rated by what they finish, not by what they attempt”

“Scientists are rated by what they finish, not by what they attempt” Physicians writing clinical manuscripts

WHAT IS PUBLISHING ALL ABOUT? Advancement of medical science

WHAT IS PUBLISHING ALL ABOUT? Advancement of medical science Improves your CV Gratifies your ego Necessary for career advancement Necessary for successful grant application Very useful to be recognized Provides proof of your scientific AND clinical competence

PROOF OF CLINICAL COMPETENCE Biondi-Zoccai et al, Catheter Cardiovasc Interv 2006

LEARNING GOALS What is publishing in interventional cardiology all about? What do we mean by current trends in publication? What is currently being published and by who? – methods – on coronary artery disease – on non-coronary heart disease – on vascular disease

TRENDS IN INTERVENTIONAL CARDIOLOGY Sources of novelties include: – Peer reviewed journals – Non-peer reviewed scientific journals – Layman journals – Peers – Sales representatives – Congresses – Government laws and directives – Reimbursement policies – Guidelines from associations or entities

HOW CAN YOU DEFINE AUTHORITY AND SUCCESS IN PUBLISHING Quantity Quality Diffusion Readership Impact factor Citation Durability

LEARNING GOALS What is publishing in interventional cardiology all about? What do we mean by current trends in publication? What is currently being published and by who? – methods – on coronary artery disease – on non-coronary heart disease – on vascular disease

METHODS FOR RECOGNIZING CURRENT TRENDS Manual search of key peer reviewed journals (NEJM, JAMA, Lancet, AIM, BMJ, JACC, Circulation, EHJ) Congresses (ACC, ESC, TCT, AHA) Electronic search of key databases (PubMed, Google Scholar) Peers

LEARNING GOALS What is publishing in interventional cardiology all about? What do we mean by current trends in publication? What is currently being published and by who? – methods – on coronary artery disease – on non-coronary heart disease – on vascular disease

1 ST GENERATION DRUG-ELUTING STENTS Stettler et al, Lancet 2007

1 ST GENERATION DRUG-ELUTING STENTS Stettler et al, Lancet 2007

1 ST GENERATION DRUG-ELUTING STENTS Stettler et al, BMJ 2008

2 ND GENERATION DRUG-ELUTING STENTS Stone et al, JAMA 2008

Stone et al, JAMA ND GENERATION DRUG-ELUTING STENTS

Stone et al, Circulation ND GENERATION DRUG-ELUTING STENTS

Stone et al, Circulation ND GENERATION DRUG-ELUTING STENTS

Onuma et al, J Am Coll Cardiol ND GENERATION DRUG-ELUTING STENTS

Onuma et al, J Am Coll Cardiol ND GENERATION DRUG-ELUTING STENTS

Fajadet et al, Circulation ND GENERATION DRUG-ELUTING STENTS

Fajadet et al, Circulation ND GENERATION DRUG-ELUTING STENTS

Windecker et al, Lancet ND GENERATION DRUG-ELUTING STENTS

Windecker et al, Lancet ND GENERATION DRUG-ELUTING STENTS

Stone et al, TCT 2009 IS PEER REVIEWED PUBLICATION SO IMPORTANT FOR YOUR PRACTICE?

Stone et al, TCT 2009 SPIRIT IV TRIAL

Stone et al, TCT 2009 SPIRIT IV TRIAL

Stone et al, TCT 2009 SPIRIT IV TRIAL

DRUG-ELUTING BALLOONS Unverdorben et al, Circulation 2009

BACK TO THE FUTURE Serruys et al, Lancet 2009

BACK TO THE FUTURE Serruys et al, Lancet 2009

DRUG-ELUTING BALLOONS Unverdorben et al, Circulation 2009

THROMBECTOMY DEVICES Burzotta et al, Eur Heart J 2009

THROMBECTOMY DEVICES Burzotta et al, Eur Heart J 2009 MANUAL THROMBECTOMYNON-MANUAL THROMBECTOMY

DIFFUSE CORONARY ARTERY DISEASE: PREVIOUS FINDINGS Hlatky et al, Lancet 2009

DIFFUSE CORONARY ARTERY DISEASE: PREVIOUS FINDINGS Hlatky et al, Lancet 2009 INCLUDING BARI EXCLUDING BARI

THE SYNTAX TRIAL Serruys et al, New Engl J Med 2009

THE SYNTAX TRIAL Serruys et al, New Engl J Med 2009

UNPROTECTED LEFT MAIN DISEASE Lee et al, J Am Coll Cardiol 2009

CHRONIC TOTAL OCCLUSIONS Valenti et al, Eur Heart J 2008

CORONARY BIFURCATION LESIONS Verheye et al, J Am Coll Cardiol 2009

OPTICAL COHERENCE TOMOGRAPHY Guagliumi et al, Catheter Cardiovasc Interv 2008

VIRTUAL HISTOLOGY Sangiorgi et al, Catheter Cardiovasc Interv 2007

FRACTIONAL FLOW RESERVE Tonino et al, New Engl J Med 2009

CHRONIC STABLE ANGINA Shaw et al, Circulation 2008

CORONARY ARTERY DISEASE IN DIABETICS BARI 2D, New Engl J Med 2009

CORONARY ARTERY DISEASE IN DIABETICS BARI 2D, New Engl J Med 2009

CORONARY ARTERY DISEASE IN DIABETICS BARI 2D, New Engl J Med 2009

ANTITHROMBOTIC THERAPY IN ACUTE CORONARY SYNDROMES Wallentin et al, New Engl J Med 2009

LEARNING GOALS What is publishing in interventional cardiology all about? What do we mean by current trends in publication? What is currently being published and by who? – methods – on coronary artery disease – on non-coronary heart disease – on vascular disease

TRANSCATHETER MITRAL VALVE REPAIR Feldman et al, J Am Coll Cardiol 2009

TRANSCATHETER MITRAL VALVE REPAIR Feldman et al, J Am Coll Cardiol 2009

TRANSCATHETER AORTIC VALVE IMPLANTATION Webb et al, J Am Coll Cardiol 2009

TRANSCATHETER AORTIC VALVE IMPLANTATION Webb et al, J Am Coll Cardiol 2009

LEFT ATRIAL APPENDIX CLOSURE Holmes et al, Lancet 2009

LEFT ATRIAL APPENDIX CLOSURE Holmes et al, Lancet 2009

LEARNING GOALS What is publishing in interventional cardiology all about? What do we mean by current trends in publication? What is currently being published and by who? – methods – on coronary artery disease – on non-coronary heart disease – on vascular disease

CAROTID ARTERY STENOSIS Ederle et al, Stroke 2009

ABDOMINAL AORTIC ANEURISM EVAR, Lancet 2005

FEMORO-POPLITEAL STENOSIS Schillinger et al, New Engl J Med 2006

BELOW-THE-KNEE INTERVENTIONS Peregrin et al, Cardiovasc Interven Radiol 2008

TAKE HOME MESSAGES

TAKE HOME MESSAGES Publishing success is a largely subjective and volatile concept Current mainstream publishing trends are shaped by key institutions, research groups, and companies Several niches are still present where high- level or otherwise successful publishing can be achieved with relative ease Yet, these can be quickly spotted and exploited in the worldwide research competition

Thank you for your attention For any correspondence: For these and further slides on these topics feel free to visit the metcardio.org website: